Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Symptomatic and Stenotic Developmental Venous Anomaly with Pontine Capillary Telangiectasia: A Case Report with Genetic Considerations. | NMC Case Rep J | 2022 | 35756188 | PubTator, text mining | PubMed |
| SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats. | Viruses | 2022 | 35746678 | PubTator, text mining | PubMed |
| Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer. | Cancers (Basel) | 2022 | 35740608 | PubTator, text mining | PubMed |
| Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma. | Front Endocrinol (Lausanne) | 2022 | 35733776 | PubTator, text mining | PubMed |
| Pathogenic mutations in the chromokinesin KIF22 disrupt anaphase chromosome segregation. | Elife | 2022 | 35730929 | PubTator, text mining | PubMed |
| A nonlinear correlation measure with applications to gene expression data. | PLoS One | 2022 | 35727808 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma. | Comput Intell Neurosci | 2022 | 35720901 | PubTator, text mining | PubMed |
| The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape. | Front Mol Biosci | 2022 | 35720127 | PubTator, text mining | PubMed |
| Coarse grained modelling highlights the binding differences in the two different allosteric sites of the Human Kinesin EG5 and its implications in inhibitor design. | Comput Biol Chem | 2022 | 35717732 | PubTator, text mining | PubMed |
| Possible association of 16p11.2 copy number variation with altered lymphocyte and neutrophil counts. | NPJ Genom Med | 2022 | 35715439 | PubTator, text mining | PubMed |
| Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine. | Dis Markers | 2022 | 35707715 | PubTator, text mining | PubMed |
| Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods. | Transl Cancer Res | 2022 | 35706800 | PubTator, text mining | PubMed |
| Identification of hub genes associated with bladder cancer using bioinformatic analyses. | Transl Cancer Res | 2022 | 35706790 | PubTator, text mining | PubMed |
| Meiotic behavior, transmission and active genes of B chromosomes in the cichlid Astatotilapia latifasciata: new clues about nature, evolution and maintenance of accessory elements. | Mol Genet Genomics | 2022 | 35704117 | PubTator, text mining | PubMed |
| Prognostic Value of NUSAP1 and Its Correlation with Immune Infiltrates in Human Breast Cancer. | Crit Rev Eukaryot Gene Expr | 2022 | 35695609 | PubTator, text mining | PubMed |
| TRAF4 Inhibits the Apoptosis and Promotes the Proliferation of Breast Cancer Cells by Inhibiting the Ubiquitination of Spindle Assembly-Associated Protein Eg5. | Front Oncol | 2022 | 35692762 | PubTator, text mining | PubMed |
| Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma. | Genes Genomics | 2022 | 35689754 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Identification of Novel circRNA-Based ceRNA Network Involved in the Pathogenesis of Gastric Cancer. | Int J Genomics | 2022 | 35685832 | PubTator, text mining | PubMed |
| Understanding the Underlying Molecular Mechanisms of Meiotic Arrest during In Vitro Spermatogenesis in Rat Prepubertal Testicular Tissue. | Int J Mol Sci | 2022 | 35682573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=41